Post job

MAP Pharmaceuticals's revenue is $23.1 million.

What is MAP Pharmaceuticals's revenue?

MAP Pharmaceuticals's annual revenue is $23.1M. Zippia's data science team found the following key financial metrics about MAP Pharmaceuticals after extensive research and analysis.
  • MAP Pharmaceuticals has 137 employees, and the revenue per employee ratio is $168,387.
  • MAP Pharmaceuticals peak revenue was $23.1M in 2024.

On this page

Peak revenue
$23.1M (2025)
Company peak revenue
Revenue / employee
$168,387
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$23.1M (2025)
Company peak revenue
Revenue / employee
$168,387
Company revenue / employee

MAP Pharmaceuticals financing

MAP Pharmaceuticals received early financing of $30.0M on 2004-09-07.

SeriesRound sizeDate
Series B$30M09/2004
Series C$25.2M01/2006
Series D$50M03/2007

MAP Pharmaceuticals investors

InvestorsSecurity type
Bay City CapitalSeries B
Skyline VenturesSeries B
Pequot CapitalSeries B
PerseusSeries C
Bay City CapitalSeries C
Skyline VenturesSeries C
ALEXANDRIA REAL ESTATE EQUITIES, INC.Series C
Brookside Capital IncSeries D
PerseusSeries D
Bay City CapitalSeries D
Skyline VenturesSeries D
D.E. Shaw & Co.Series D
Pequot CapitalSeries D

MAP Pharmaceuticals competitors

MAP Pharmaceuticals's top competitor, Hoffmann-LA Roche Inc, earned an annual revenue of $60.9B.

MAP Pharmaceuticals's smallest competitor is Seelos Therapeutics with revenue of $375.0K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Adamis Pharmaceuticals-$4.8M131-
Satsuma Pharmaceuticals-$492.9M5-
Pulmatrix-$7.8M22-
Seelos Therapeutics-$375,00010-
Apellis Pharmaceuticals-$781.4M200-
Civitas Therapeutics-$72.9M20-
Delcath Systems-$37.2M36-
Hoffmann-LA Roche Inc-$60.9B101,200-
PTC Therapeutics-$806.8M517-
Ariad Pharmaceuticals-$118.8M380-

MAP Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of MAP Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MAP Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at MAP Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MAP Pharmaceuticals. The data presented on this page does not represent the view of MAP Pharmaceuticals and its employees or that of Zippia.

MAP Pharmaceuticals may also be known as or be related to MAP PHARMACEUTICALS, INC., MAP Pharmaceuticals and Map Pharmaceuticals.